J&J Innovation Showcase

  • 28 January 2018
  • 12.00 - 14.00
  • Citylabs 1.0
Sign up


J&J Innovation Showcase

For any companies working in the MedTech, Digital Health and Biotech sectors who interested in collaborating with Johnson & Johnson Innovation, don’t miss this unique opportunity to join Mirren Mandalia, Senior Director for New Ventures and Transactions at Citylabs 1.0. During this event you will be able to explore partnership opportunities and how J&J can help you tap into a global network of science and technology experts, access technologies, funding and other resources that can speed up the development of your innovative products and services.

Please note that J&J is more interested in developments that are near to reaching the market than earlier stage developments.

About J&J:

Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses.

Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation – JLABS, Johnson & Johnson Innovation – JLINX, Johnson & Johnson Innovation – JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information, visit www.jnjinnovation.com or follow @JNJInnovation.


12 - 12.30: Arrival & Lunch

12.30 - 13.15 – Presentation and Q&A / Discussion

13.15 - 14.00 - Networking

About the speaker:

Mirren Mandalia is Senior Director of New Ventures & Transactions and Medical Devices at Johnson & Johnson Innovation. He leads identification and transactions of innovative early stage medical devices, to support Johnson & Johnson across EMEA.

He joined Johnson & Johnson in 2013 leading a number of programmes leveraging innovative digital platforms to empower patients, improve clinical workflows & patient outcomes across a variety of clinical specialties. Prior to this role he was a member of the healthcare practice at The Boston Consulting Group in London, advising pharma, medtech, payers and providers on key strategic issues including business development, growth strategies and sales & marketing. Over the past few years, he has also been an advisor for a number of healthcare start-ups.

Mirren is a trained surgeon with expertise in General Surgery and Plastics & Reconstructive Surgery, and held surgical posts at major teaching hospitals including University College Hospital, Royal Free Hospital and St George’s Hospital. He qualified as a doctor at St. George’s Medical School, University of London, and undertook research on innovative surgical technologies, including on virtual reality simulators and motion analysis, with Lord Ara Darzi at Imperial College, London. He is a Member of the Royal College of Surgeons of England and he received an MBA from London Business School.

Sign up